Physician profile
Paula L Countiss
NPI 1649205907
$2,481.61
in general payments reported to CMS, 2019-2025
13 companies · $77.25 in 2025
The $77.25 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,348 · 2022: $748 · 2023: $240 · 2024: $68.47 · 2025: $77.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $599.52 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $483.91 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $474.46 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $368.77 | 2021-2022 | |
| Esperion Therapeutics, INC. | $141.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $112.92 | 2021-2022 | |
| Abbott Laboratories | $88.11 | 2021 | |
| Abiomed | $84.51 | 2021 | |
| Pfizer INC. | $47.25 | 2021-2022 | |
| Irhythm Technologies, INC. | $26.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.72 | 2022 | |
| Baxter Healthcare | $18.04 | 2022 | |
| Daiichi Sankyo INC. | $16.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paula Countiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.